openPR Logo
Press release

New Research Study on Monoclonal Antibodies Market: Key Players involved in the research - AbbVie, Roche, Johnson & Johnson, Amgen, Merck, BMS, Eli Lilly, Formation Biologics

New Research Study on Monoclonal Antibodies Market

New Research Study on Monoclonal Antibodies Market

HTF MI recently introduced Global Monoclonal Antibodies Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Roche, Johnson & Johnson, Amgen, Merck, BMS, Eli Lilly, Formation Biologics, Genmab, GlaxoSmithKline, Human Genome Sciences, mmunogen, MedImmune, Novartis, Pfizer, Seattle Genetics, Stemcentrx, Synthon Biopharmaceuticals, Takeda & Teva etc.

Request Sample of Global Monoclonal Antibodies Market Research Report 2018 @: https://www.htfmarketreport.com/sample-report/1283834-global-monoclonal-antibodies-market-3

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
The global Monoclonal Antibodies market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

This report studies the Global Monoclonal Antibodies market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the Global Monoclonal Antibodies market by companies, region, type and end-use industry.

Browse 100+ market data Tables and Figures spread through Pages and in-depth TOC on " Monoclonal Antibodies Market by Type (Cancer, Autoimmune Diseases, Infection, Hematological Diseases & Others), by End-Users/Application (Oncology, Autoimmune and inflammatory diseases, Respiratory diseases & Ophthalmology), Organization Size, Industry, and Region - Forecast to 2023". Early buyers will receive 10% customization on comprehensive study.

In order to get a deeper view of Market Size, competitive landscape is provided i.e. Revenue (Million USD) by Players (2013-2018), Revenue Market Share (%) by Players (2013-2018) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Enquire for customization in Report @ https://www.htfmarketreport.com/enquiry-before-buy/1283834-global-monoclonal-antibodies-market-3

Competitive Analysis:
The key players are highly focusing innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies. Company profile section of players such as AbbVie, Roche, Johnson & Johnson, Amgen, Merck, BMS, Eli Lilly, Formation Biologics, Genmab, GlaxoSmithKline, Human Genome Sciences, mmunogen, MedImmune, Novartis, Pfizer, Seattle Genetics, Stemcentrx, Synthon Biopharmaceuticals, Takeda & Teva includes its basic information like legal name, website, headquarters, its market position, historical background and top 5 closest competitors by Market capitalization / revenue along with contact information. Each player/ manufacturer revenue figures, growth rate and gross profit margin is provided in easy to understand tabular format for past 5 years and a separate section on recent development like mergers, acquisition or any new product/service launch etc.

Market Segments:
The Global Monoclonal Antibodies Market has been divided into type, application, and region.
On The Basis Of Type: Cancer, Autoimmune Diseases, Infection, Hematological Diseases & Others.
On The Basis Of Application: Oncology, Autoimmune and inflammatory diseases, Respiratory diseases & Ophthalmology
On The Basis Of Region, this report is segmented into following key geographies, with production, consumption, revenue (million USD), and market share, growth rate of Monoclonal Antibodies in these regions, from 2013 to 2023 (forecast), covering
• North America (U.S. & Canada) {Market Revenue (USD Billion), Growth Analysis (%) and Opportunity Analysis}
• Latin America (Brazil, Mexico & Rest of Latin America) {Market Revenue (USD Billion), Growth Share (%) and Opportunity Analysis}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) {Market Revenue (USD Billion), Growth Share (%) and Opportunity Analysis}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) {Market Revenue (USD Billion), Growth Share (%) and Opportunity Analysis}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA) {Market Revenue (USD Billion), Growth Share (%) and Opportunity Analysis}
• Rest of World {Market Revenue (USD Billion), Growth Analysis (%) and Opportunity Analysis}

Buy Single User License of Global Monoclonal Antibodies Market Research Report 2018 @ https://www.htfmarketreport.com/buy-now?format=1&report=1283834

Have a look at some extracts from Table of Content

Introduction about Global Monoclonal Antibodies

Global Monoclonal Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2017
Monoclonal Antibodies Market by Application/End Users
Global Monoclonal Antibodies Sales (Volume) and Market Share Comparison by Applications
(2013-2023) table defined for each application/end-users like [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases & Ophthalmology]
Global Monoclonal Antibodies Sales and Growth Rate (2013-2023)
Monoclonal Antibodies Competition by Players/Suppliers, Region, Type and Application
Monoclonal Antibodies (Volume, Value and Sales Price) table defined for each geographic region defined.
Global Monoclonal Antibodies Players/Suppliers Profiles and Sales Data

Additionally Company Basic Information, Manufacturing Base and Competitors list is being provided for each listed manufacturers

Market Sales, Revenue, Price and Gross Margin (2013-2018) table for each product type which include Cancer, Autoimmune Diseases, Infection, Hematological Diseases & Others
Monoclonal Antibodies Manufacturing Cost Analysis
Monoclonal Antibodies Key Raw Materials Analysis
Monoclonal Antibodies Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
Market Forecast (2018-2023)
........and more in complete table of Contents

Browse for Full Report at: https://www.htfmarketreport.com/reports/1283834-global-monoclonal-antibodies-market-3

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

Connect with us at
https://www.linkedin.com/company/13388569/
https://www.facebook.com/htfmarketintelligence/
https://twitter.com/htfmarketreport
https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Research Study on Monoclonal Antibodies Market: Key Players involved in the research - AbbVie, Roche, Johnson & Johnson, Amgen, Merck, BMS, Eli Lilly, Formation Biologics here

News-ID: 1159312 • Views:

More Releases from HTF Market Intelligence Consulting Pvt. Ltd.

Ultrahigh-Pressure Waterjet Market Analysis Current and Future Growth Scenario | Altrad Group, Aquarese Industries, Bystronic
Ultrahigh-Pressure Waterjet Market Analysis Current and Future Growth Scenario | …
Latest Study on Industrial Growth of Global Ultrahigh-Pressure Waterjet Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the Ultrahigh-Pressure Waterjet market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends
Virtual Account System Market Growth Potential is Booming Now | TietoEVRY, Cashfac, Montran
Virtual Account System Market Growth Potential is Booming Now | TietoEVRY, Cashf …
Latest Study on Industrial Growth of Virtual Account System Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the Virtual Account System market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future
Web and Video Conferencing Software Market Is Projected to Grow At A CAGR of 12.5 % through 2030 | Cisco, Microsoft, Google
Web and Video Conferencing Software Market Is Projected to Grow At A CAGR of 12. …
Latest Study on Industrial Growth of Web and Video Conferencing Software Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the Web and Video Conferencing Software market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete
Wireless Network Infrastructure Ecosystem Market Shaping from Growth to Value | ABB, Cisco, Huawei
Wireless Network Infrastructure Ecosystem Market Shaping from Growth to Value | …
Latest Study on Industrial Growth of Wireless Network Infrastructure Ecosystem Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the Wireless Network Infrastructure Ecosystem market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of

All 5 Releases


More Releases for Monoclonal

Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for …
Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017,
Monoclonal Antibodies Market Outline and Updates..!!
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into
Global Monoclonal Antibody Diagnostic Reagents Market
Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity